Indicators on Niraparib You Should Know
Identify your assortment: Title has to be under people Opt for a group: Unable to load your selection as a result of an errorIn 2006, its maker AstraZeneca announced that it would not make an effort to industry ximelagatran following studies of hepatotoxicity (liver hurt) in the course of trials, also to discontinue its distribution in nations arou